Filter
358
Filtered Results: 358
Text search:
GMP
Featured
Recommendations
41
New Publications
102
Language
Document type
No document type
174
Guidelines
70
Studies & Reports
48
Manuals
32
Strategic & Response Plan
17
Fact sheets
8
Training Material
6
Situation Updates
3
Countries / Regions
India
18
Nepal
14
Kenya
14
Ethiopia
12
Global
10
Uganda
10
Sierra Leone
9
Nigeria
9
Zambia
9
Tanzania
8
Latin America and the Carribbean
7
South Africa
7
Namibia
7
Liberia
7
Ghana
6
Western and Central Europe
6
Zimbabwe
5
Bangladesh
5
Germany
4
Middle East and North Africa
4
South–East Asia Region
4
North America
4
Botswana
4
Indonesia
4
Rwanda
3
Philippines
3
Africa
3
Russia
3
South Sudan
3
Tajikistan
2
Colombia
2
Syria
2
Senegal
2
Malawi
2
Eastern Europe and Central Asia
2
Eastern Europe
2
Brazil
2
Yemen
2
Myanmar / Burma
2
Eswatini/ Swaziland
2
Thailand
1
Ukraine
1
Lesotho
1
Cameroon
1
Iran
1
Albania
1
Laos
1
Burkina Faso
1
Guinea
1
Mozambique
1
Cambodia
1
Guinea-Bissau
1
Jordan
1
Congo, Democratic Republic of
1
West and Central Africa
1
Western Pacific Region
1
Turkmenistan
1
Maldives
1
United Kingdom
1
Spain
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Sri Lanka
1
Mali
1
Angola
1
Bhutan
1
Somalia
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
159
Clinical Guidelines
50
Public Health
30
Pharmacy & Technologies
28
Key Resources
16
Capacity Building
11
Women & Child Health
10
Toolboxes
Pharmacy
40
AMR
36
COVID-19
25
Planetary Health
15
TB
14
NTDs
10
Rapid Response
8
Malaria
8
Ebola & Marburg
7
Refugee
4
Zika
4
Global Health Education
4
Natural Hazards
3
HIV
2
Conflict
2
Cholera
1
Caregiver
1
Health Financing Toolbox
1
NCDs
1
Polio
1
Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021
recommended
The latest update (28 January 2021) includes the following addition and revision:
biosafety aspects for working with antigen-detecting rapid diagnostic test;
handling new variants of SARS-CoV-2 in the laboratory;
updated assay decontamination before disposal;
personal protectiv...
Hepatitis aguda de etiología desconocida en niños: Orientaciones provisionales para los laboratorios
Este documento ofrece una orientación provisional a los países sobre las consideraciones y estrategias de análisis para los casos sospechosos de hepatitis aguda grave de etiología desconocida en niños. Está dirigido principalmente a las partes interesadas en el ámbito clínico, programático,...
Nepal is the world’s third most polluted country. Air pollution shortens average Nepalese life expectancy by 4.1 years, relative to what it would be if the World Health Organization (WHO) guideline of 5 μg/m3 was met.1 The highest concentrations of air pollution are observed in Nepal’s southwes...
This manual has been prepared by the Group on Agriculture of the FAO Regional Office for Latin America and the Caribbean. The purpose of this work is to spread the basic concepts of Good Agricultural Practices (GAP)in order to: guide the production systems towards a sustainable agriculture and ecolo...
The WHO BioHub Biosafety & Biosecurity: criteria and operational modalities sets out the requirements to which laboratories wishing to receive biological materials as part of this international exchange system should abide, to ensure safe and secure operations. These provisions are in accordance wit...
Данный Национальный план в области Устойчивости к противомикробным пре- паратам (УПП) с компонентом потребления противомикробных препаратов (ППП), для секторов зд...
O objetivo deste documento é fornecer orientações provisórias de biossegurança laboratorial para testes com amostras clínicas de pacientes que atendam à definição de casos do novo patógeno identificado em Wuhan, China, ou seja, a doença do coronavírus 2019 (COVID-19). A OMS revisará ess...
India is the world’s second most polluted country. Air pollution shortens average Indian life expectancy by 5 years,
relative to what it would be if the World Health Organization (WHO) guideline fine particulate pollution (PM2.5) of 5 μg/m3 was met. Some areas of India fare much worse than avera...
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from...
The report summarizes the estimates of the burden of disease attributable to unsafe drinking water, sanitation, and hygiene for the year 2019 for four health outcomes - diarrhoea, acute respiratory infections, soil-transmitted helminthiases, and undernutrition - which are included in the reporting o...
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
procédures : guide méthodologique
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
Lignes directrices de l'OMS sur le paludisme
recommended
Les Lignes directrices de l'OMS sur le paludisme rassemblent les recommandations les plus récentes de l'Organisation pour le paludisme dans une plateforme en ligne conviviale et facile à naviguer.
Les Lignes directrices de l'OMS sur le paludisme remplacent 2 publications précédentes de l'OMS: l...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
